The Biologics Manufacturing Center (BMC) inc. is a new biomanufacturing facility created in response to the pandemic. A not-for-profit organization, the BMC aims to better meet the biopharmaceutical needs of Canadians. The BMC helps support projects of public interest, actively contributes to the overall growth and resilience of the Canadian life sciences industry, and fosters industry development and innovation through Canadian production. Rich in committed and innovative employees, the BMC fosters a culture of agility and transparency with a collaborative, results-oriented approach. The BMC, an organization like no other - Our team is made up of talented, committed people with diverse backgrounds. - We aim to develop, share and transmit knowledge - Our NPO status enables us to reinvest every dollar of profit back into the organization. - Our human scale enables all our employees to participate in driving the company forward - Our economic positioning is unique in our industry - Our social mission is extraordinary The BMC, a key player in Canadian biotech production The BMC is a new facility in the heart of Montreal, completed in June 2021. It supports the growth of the country's biologics production capacity, ensuring that vaccines and other related products can be manufactured safely, right here at home. Thanks to its state-of-the-art facilities and the knowledge of its team, the BMC can produce biopharmaceutical products such as viral vector, protein subunit and virus-like particle vaccines, as well as other biological products. It is a key player in Canada's ability to respond rapidly to future national and global health emergencies.
Employee reviews
Check out your Company Bowl for anonymous work chats.
